Lead Product(s) : Tocilizumab,Methotrexate
Therapeutic Area : Immunology
Study Phase : Undisclosed
Sponsor : Theramex
Deal Size : Undisclosed
Deal Type : Agreement
Details : Theramex has entered into an agreement with Enzene Biosciences to develop, register and commercialise a biosimilar drug of Roche’s reference medicine RoActemra® (Tocilizumab). Tocilizumab will be available in parenteral vials, subcutaneous prefilled s...
Brand Name : Undisclosed
Molecule Type : Large molecule
Upfront Cash : Undisclosed
December 23, 2021
Lead Product(s) : Tocilizumab,Methotrexate
Therapeutic Area : Immunology
Highest Development Status : Undisclosed
Sponsor : Theramex
Deal Size : Undisclosed
Deal Type : Agreement
LOOKING FOR A SUPPLIER?